quadraScope Venture Fund participated in an investor panel at the 2022 Longevity Investors Conference admin September 20, 2022
quadraScope Venture Fund’s presentation at the Ending Age-Related Diseases 2022 Conference admin August 13, 2022 Visit the conference program here
The 9th ARDD: Longevity Biotechnology Is Gaining Prominence and Credibility in the Pharmaceutical Industry admin August 11, 2022
Portfolio: Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy admin August 9, 2022
